You are here
Following the completion of the 2016 Inter-Rater Reliability (IRR) study to test the consistency of clinician application of the mental health phase of care, the poor to fair reliability outcome led to the commencement of the refinement project.
The Independent Hospital Pricing Authority (IHPA) is currently developing a new classification for non-admitted care - the Australian Non-Admitted Care Classification (ANACC) - in response to the recommendations of public consultations in 2013 and 2014 on non-admitted care classification.
This document provides background to the development of the new classification, explains the data elements and collection protocols, reporting requirements, and how the data is grouped.
The Inter-rater reliability study final report was approved by the Pricing Authority in April 2017. The primary aims of the study were to test the inter-rater reliability of the mental health phase of care instrument, gather information about the clinicians' views of the mental health phase of care, identifying ways of increasing the clarity to reduce the ambiguity of the instrument, and to provide recommendations on how the instrument may be refined.
The purpose of this costing study was to undertake a Teaching, Training and Research (TTR) cost and activity data collection at a representative sample of Australian hospitals and produce costed data to inform the development of a TTR classification.
This document provides information for clinicians to enable them to assess phases accurately when applying the new concept of mental health phase of care.
This document describes the Australian Mental Health Care Classification and the process IHPA has undertaken to develop the new classification.
The purpose of this costing study was to undertake an analysis of CALD patients to inform a policy decision for whether an adjustment is warranted to the National Efficient Price for CALD patients.
The non-admitted study was comprehensive across a range of settings (e.g. outpatients, community and satellite clinics). Similarly all service streams were included regardless of funding source. This ensured that all services were accounted for and costed appropriately providing an accurate cost of delivering multiple services across multiple settings (e.g. overhead costs are apportioned across all patients).
The purpose of this report is to review the costs of providing care to Indigenous patients accessing public hospital services. This work was commissioned in response to stakeholder concerns that the national activity based funding system does not adequately reflect Indigenous patient costs.
Home Enteral Nutrition, Home Total Parenteral Nutrition and Home Ventilation Services Costing Study Report16 January 2015
The Costing study on Home Enteral Nutrition, Home Total Parenteral Nutrition and Home Ventilation Services was undertaken in 2014. The purpose of the study was to review the costs associated with the delivery of public hospital services to patients receiving home enteral nutrition, home total parenteral nutrition and home ventilation services. The study include a literature review, stakeholder consultation and costing the respective services based on data collected from the jurisdictions.
IHPA values the feedback it receives from jurisdictions, peak bodies, other interested stakeholder groups, and the community as it progresses work to develop and refine the Australian Mental Health Care Classification (AMHCC) and its supporting material, both in the immediate future and the longer term.
The costing study on home delivered dialysis was undertaken in 2014. The purpose of the study was to collate and compare the range of costing studies and economic evaluations that have been carried out on these services over the past decade.
The report identifies two key studies - NSW Dialysis Costing Study, conducted in 2008, and Queensland Health Renal Replacement Therapy Costing Study, conducted in 2008 - which are useful in estimating the current costs of home-based dialysis.
PwC and its sub-contractor The Independent Hospital Pricing Authority (IHPA) engaged PwC and its sub-contractor SyRis Consulting to undertake a review and costing study of Australian radiotherapy services. The study was commissioned to determine the reliability of radiotherapy cost data due to its role in the development of associated price weights in both admitted and non-admitted settings.